BRIEF-U.S. FDA approves Juluca, a two-drug regimen for certain patients with HIV By: Reuters: Company News November 21, 2017 at 14:04 PM EST * Approved Juluca, a fixed-dose tablet containing dolutegravir and rilpivirine, to treat adults with HIV-1 infections Read More >> Related Stocks: Gsk Plc ADR Pfizer